18-Methoxycoronaridine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "18-Methoxycoronaridine" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
2,726th place
1,608th place
2,970th place
1,588th place
5,225th place
4,062nd place
low place
low place
18th place
17th place
6,834th place
4,564th place
102nd place
76th place

clinicaltrials.gov

doi.org

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

mindmed.co

newswire.ca

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Glick SD, Kuehne ME, Maisonneuve IM, Bandarage UK, Molinari HH (May 1996). "18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats". Brain Research. 719 (1–2): 29–35. doi:10.1016/0006-8993(96)00056-X. PMID 8782860. S2CID 6178161.
  • Maisonneuve IM, Glick SD (June 2003). "Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment". Pharmacology, Biochemistry, and Behavior. 75 (3): 607–18. doi:10.1016/S0091-3057(03)00119-9. PMID 12895678. S2CID 26758480.
  • Taraschenko OD, Shulan JM, Maisonneuve IM, Glick SD (July 2007). "18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens". Synapse. 61 (7): 547–60. doi:10.1002/syn.20396. PMID 17447255. S2CID 2252348.
  • Arias HR, Tae HS, Micheli L, Yousuf A, Ghelardini C, Adams DJ, Di Cesare Mannelli L (September 2020). "Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels". Neuropharmacology. 175: 108194. doi:10.1016/j.neuropharm.2020.108194. hdl:2158/1213504. PMID 32540451. S2CID 219705597.

timesunion.com

uow.edu.au

ro.uow.edu.au